{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:38:40Z","timestamp":1791959920957,"version":"4.3.4"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0301-4738.116456","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T06:16:06Z","timestamp":1389248166000},"page":"765","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma"],"prefix":"10.4103","volume":"61","author":[{"given":"PramodB","family":"Akat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SachinR","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaiprakashB","family":"Ramanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SunitaJ","family":"Ramanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VitthalB","family":"Karande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuyogS","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.116456-1","first-page":"701","volume-title":"The ocular hypertension treatment study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.116456-2","first-page":"1954","volume-title":"The collaborative initial glaucoma treatment study: Interim quality of life findings after initial medical or surgical treatment of glaucoma","author":"Janz","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.116456-3","first-page":"A 12","volume-title":"Twice-daily 0.2% brimonidine-0","author":"Sherwood","year":"5% t","journal-title":""},{"key":"key-10.4103\/0301-4738.116456-4","first-page":"39","volume-title":"A short term study of the additive effect of timolol and brimonidine on intraocular pressure","author":"Arici","year":"2002","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.116456-5","first-page":"1268","volume-title":"Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.116456-6","first-page":"1217","volume-title":"Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells","author":"Ayaki","year":"2010","journal-title":"Clin Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:23:11Z","timestamp":1786648991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.116456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"alternative-id":["116456"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.116456","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}